Document is current
Any future updates will be listed below
-
Authors
Friedel, Evelyn B.N. https://orcid.org/0000-0001-9862-9656
Beringer, Malina https://orcid.org/0009-0009-3337-2357
Endres, Dominique https://orcid.org/0000-0001-7322-1195
Runge, Kimon https://orcid.org/0000-0002-0263-4360
Maier, Simon https://orcid.org/0000-0002-7326-7422
Küchlin, Sebastian https://orcid.org/0000-0003-0758-5120
Kornmeier, Jürgen https://orcid.org/0000-0001-7798-3541
Domschke, Katharina https://orcid.org/0000-0002-2550-9132
Heinrich, Sven P. https://orcid.org/0000-0003-4906-3937
Tebartz van Elst, Ludger https://orcid.org/0000-0002-2274-5447
Nickel, Kathrin https://orcid.org/0000-0001-9863-317X
-
Funding
Funding for this research was provided by:
Universitätsklinikum Freiburg
- License Information
-
More Information
Article History
Received: 17 February 2025
Accepted: 25 March 2025
First Online: 9 April 2025
Declarations
:
: The Ethics Committee of the University of Freiburg (Approval ID: 314/18) approved the study. All participants gave written informed consent to participate.
: The manuscript contains no individual person’s data.
: EF, MBe, DE, KR, SM, SK, JK, SH, KN: no conflict of interest. LTvE: Advisory boards, lectures, or travel grants within the last 3 years: Roche, Eli Lilly, Janssen-Cilag, Novartis, Shire, UCB, GSK, Servier, Janssen, and Cyberonics.KD: Formerly: Steering Committee Neurosciences and speaker honoraria, Janssen-Cilag, within the last three years. Member of the Neurotorium Editorial Board, The Lundbeck Foundation.
